|
Title
|
Publication Date
|
Price
|
Relevance
|
New Approaches to Gaining Market Access for Pharmaceuticals
Pricing & Reimbursement, Policy Development, and the Role of HTAs
|
Oct 2010 |
£2,425 |
100% |
Patient Empowerment
Empowered Patients Can Change Healthcare Outcomes And Impact The Pharmaceutical Industry
|
Jul 2007 |
£3,600 |
99% |
Chemotherapy Market Insights, 2006-2016
A Critical Analysis of Cancer Research, Treatments, Pipelines, and Commercial Opportunities
|
Apr 2006 |
£1,900 |
92% |
Market Access Europe
It's Not Just About Price
|
May 2011 |
£535 |
92% |
Preparing Health Technology Submissions for Pharmaceutical Products
Meeting Formulary Submission Requirements for New Product Assessments and Disease Area & Therapeutic Class Reviews
|
Apr 2006 |
£1,550 |
90% |
|
Creating compelling market access stories
|
Aug 2011 |
£355 |
89% |
Saudi Arabia Pharmaceuticals and Healthcare Report
Q2 2011
|
Mar 2011 |
£330 |
88% |
How Drugs Are Developed
3rd Edition
|
Jan 2007 |
£1,095 |
88% |
Peru Pharmaceuticals and Healthcare Report Q3
2011
|
Jun 2011 |
£330 |
87% |
|
Global Trends in Reimbursement of Medical Technology
|
Jan 2007 |
£1,300 |
87% |
|
Payer Agreements: Splitting the Risk
|
Oct 2011 |
£495 |
87% |
|
Complete Guide to the 2009 PPRS, NICE and other Pharmaceutical Cost Containment Measures in the United Kingdom
|
Apr 2009 |
£850 |
87% |
Innovative R&D Strategies and Models
Outsourcing, Strategic Partnerships and Licensing to Improve Productivity and Contain Costs
|
Sep 2011 |
£2,215 |
87% |
Croatia Pharmaceuticals and Healthcare Report
Q2 2011
|
Feb 2011 |
£330 |
83% |
Healthcare Toolkits
Empowering Consumers Through Education
|
Sep 2005 |
£61 |
83% |
Germany Pharmaceuticals and Healthcare Report Q1
2012
|
Dec 2011 |
£330 |
82% |
|
United Kingdom Pharmaceuticals and Healthcare Report Q1 2009
|
Jan 2009 |
£330 |
82% |
GenericHandbook - Third Edition (2009)
A Guide to the Generic Drug Industry in the US
|
Apr 2009 |
£475 |
82% |
Health Technology Assessment (HTA)
A European perspective
|
Oct 2011 |
£735 |
82% |
|
Competitive Profiling of Market Participants in Lifesciences-IT
|
Apr 2009 |
£4,110 |
81% |
Thailand Pharmaceuticals and Healthcare Report Q4
2011
|
Aug 2011 |
£330 |
81% |
|
The Pharmaceutical Market: UK
|
Oct 2011 |
£595 |
79% |
|
Lundbeck: Pipeline - Products - Performance - Potential
|
Jun 2010 |
£595 |
79% |
Qatar Pharmaceuticals and Healthcare Report Q3
2011
|
Jun 2011 |
£330 |
79% |
Implantable Medical Devices
US industry forecasts for 2014 & 2019
|
Mar 2010 |
£3,035 |
79% |
Bulgaria Pharmaceuticals and Healthcare Report Q3
2011
|
Jun 2011 |
£330 |
79% |
Kuwait Pharmaceuticals and Healthcare Report Q4
2011
|
Sep 2011 |
£330 |
79% |
Kazakhstan Pharmaceuticals and Healthcare Report Q3
2011
|
Jun 2011 |
£330 |
78% |
Taiwan Pharmaceuticals and Healthcare Report Q1
2012
|
Nov 2011 |
£330 |
78% |
|
Analyzing the Generic Drugs Sector of the US Pharmaceutical Industry
|
May 2010 |
£410 |
78% |
